
Dynatrace, Inc.
DTNYSETechnology● Active
$42.19
$-1.06(-2.45%)
Market Cap$12.3B
P/E Ratio—
52W High$57.55
52W Low$31.635
Dynatrace, Inc.(DT)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · DT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.02B | $1.70B | $1.43B | $1.16B | $0.93B |
| Cost of Revenue | $0.37B | $0.32B | $0.27B | $0.22B | $0.17B |
| Gross Profit | $1.65B | $1.38B | $1.16B | $0.94B | $0.76B |
| Gross Margin %(computed) | 81.56% | 81.15% | 81.37% | 80.76% | 81.40% |
| Operating Expenses | |||||
| R&D Expenses | $0.47B | $0.38B | $0.30B | $0.22B | $0.16B |
| G&A Expenses | $0.22B | $0.20B | $0.17B | $0.15B | $0.13B |
| Total Operating Expenses | $1.38B | $1.20B | $1.04B | $0.84B | $0.68B |
| Operating Income | $0.26B | $0.18B | $0.13B | $0.09B | $0.08B |
| Operating Margin %(computed) | 13.08% | 10.56% | 8.98% | 8.01% | 8.75% |
| Interest Income | $0.05B | $0.05B | $0.04B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Income Before Tax | $0.30B | $0.22B | $0.15B | $0.09B | $0.07B |
| Income Tax Expense | $0.14B | ($0.26B) | $0.00B | ($0.02B) | $0.02B |
| Net Income | $0.16B | $0.48B | $0.15B | $0.11B | $0.05B |
| Net Margin %(computed) | 8.06% | 28.47% | 10.81% | 9.32% | 5.64% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.54 | $1.62 | $0.53 | $0.38 | $0.18 |
| Wtd Avg Shares | 0.30B | 0.30B | 0.29B | 0.29B | 0.28B |
| EBITDA | $0.29B | $0.23B | $0.18B | $0.15B | $0.14B |
| EBITDA Margin %(computed) | 14.27% | 13.39% | 12.82% | 12.72% | 14.87% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解Dynatrace, Inc.
关于Dynatrace, Inc.(DT)损益表
Dynatrace, Inc.(DT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年,DT实现营收$2.02B,毛利润$1.65B(毛利率81.56%),净利润$0.16B(净利率8.06%)。
常见问题
DT · 4 问Dynatrace, Inc.(DT)2026财年营收为$2.02B,同比up18.8%。
DT revenueDT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08